Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04329949 · TERMINATED
Trial details
- NCT number
- NCT04329949
- Sponsor
- Corcept Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-08-23
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.